Search the Appendices of Resolution CM/Res(2018)1
1941 found
INN | ATC Code ▲ | Country | Classification | Last update | MA Number | Registration date | Status | |
---|---|---|---|---|---|---|---|---|
REGORAFENIB | L01EX05 | SI | POM | VALID | ||||
CABOZANTINIB | L01EX07 | SI | POM | VALID | ||||
LENVATINIB | L01EX08 | SI | POM | VALID | ||||
NINTEDANIB | L01EX09 | SI | POM | VALID | ||||
QUIZARTINIB | L01EX11 | SI | Not authorised | 05-05-2025 | EMEA/H/C/005910 | 06-11-2023 | VALID | |
GILTERITINIB | L01EX13 | SI | POM | VALID | ||||
RIPRETINIB | L01EX19 | SI | POM | VALID | ||||
CAPIVASERTIB | L01EX27 | SI | POM | 22-10-2024 | EMEA/H/C/006017 | 17-06-2024 | VALID | |
REPOTRECTINIB | L01EX28 | SI | POM | 05-05-2025 | EMEA/H/C/006005 | 13-01-2025 | VALID | |
RITUXIMAB | L01FA01 | SI | POM | VALID | ||||
OFATUMUMAB | L01FA02 | SI | Not authorised | 05-05-2025 | VALID | |||
OBINUTUZUMAB | L01FA03 | SI | POM | VALID | ||||
INOTUZUMAB OZOGAMICIN | L01FB01 | SI | POM | VALID | ||||
MOXETUMOMAB PASUDOTOX | L01FB02 | SI | Not authorised | VALID | ||||
DARATUMUMAB | L01FC01 | SI | POM | VALID | ||||
ISATUXIMAB | L01FC02 | SI | POM | VALID | ||||
TRASTUZUMAB | L01FD01 | SI | POM | VALID | ||||
PERTUZUMAB | L01FD02 | SI | POM | VALID | ||||
TRASTUZUMAB EMTANSINE | L01FD03 | SI | POM | VALID | ||||
TRASTUZUMAB DERUXTECAN | L01FD04 | SI | POM | VALID | ||||
PANITUMUMAB | L01FE02 | SI | POM | VALID | ||||
NIVOLUMAB | L01FF01 | SI | POM | VALID | ||||
PEMBROLIZUMAB | L01FF02 | SI | POM | VALID | ||||
DURVALUMAB | L01FF03 | SI | POM | VALID | ||||
AVELUMAB | L01FF04 | SI | POM | VALID | ||||
CEMIPLIMAB | L01FF06 | SI | POM | VALID | ||||
DOSTARLIMAB | L01FF07 | SI | POM | 05-05-2025 | VALID | |||
TISLELIZUMAB | L01FF09 | SI | POM | 14-11-2023 | EMEA/H/C/005919 | 15-09-2023 | VALID | |
RETIFANLIMAB | L01FF10 | SI | Not authorised | 05-05-2025 | EMEA/H/C/006194 | 19-04-2024 | VALID | |
SERPLULIMAB | L01FF12 | SI | POM | 05-05-2025 | EMEA/H/C/006170 | 03-02-2025 | VALID | |
TORIPALIMAB | L01FF13 | SI | Not authorised | 05-05-2025 | EMEA/H/C/006120 | 19-09-2024 | VALID | |
RAMUCIRUMAB | L01FG02 | SI | POM | VALID | ||||
GEMTUZUMAB OZOGAMICIN | L01FX02 | SI | POM | VALID | ||||
CATUMAXOMAB | L01FX03 | SI | POM | 05-05-2025 | EMEA/H/C/005697 | 10-02-2025 | VALID | |
IPILIMUMAB | L01FX04 | SI | POM | VALID | ||||
BRENTUXIMAB VEDOTIN | L01FX05 | SI | POM | VALID | ||||
DINUTUXIMAB BETA | L01FX06 | SI | POM | VALID | ||||
BLINATUMOMAB | L01FX07 | SI | POM | VALID | ||||
ELOTUZUMAB | L01FX08 | SI | Not authorised | VALID | ||||
MOGAMULIZUMAB | L01FX09 | SI | POM | 15-07-2020 | VALID | |||
OLARATUMAB | L01FX10 | SI | Not authorised | VALID | ||||
POLATUZUMAB VEDOTIN | L01FX14 | SI | POM | VALID | ||||
SACITUZUMAB GOVITECAN | L01FX17 | SI | POM | VALID | ||||
AMIVANTAMAB | L01FX18 | SI | POM | VALID | ||||
TREMELIMUMAB | L01FX20 | SI | POM | 18-08-2023 | EMEA/H/C/004650 | 20-02-2023 | VALID | |
LONCASTUXIMAB TESIRINE | L01FX22 | SI | POM | 18-08-2023 | EMEA/H/C/005685 | 20-12-2022 | VALID | |
MIRVETUXIMAB SORAVTANSINE | L01FX26 | SI | POM | 05-05-2025 | EMEA/H/C/005036 | 14-11-2024 | VALID | |
GLOFITAMAB | L01FX28 | SI | POM | 14-11-2023 | EMEA/H/C/005751 | 07-07-2023 | VALID | |
TALQUETAMAB | L01FX29 | SI | POM | 06-05-2025 | VALID | |||
ZOLBETUXIMAB | L01FX31 | SI | POM | 22-10-2024 | EMEA/H/C/005868 | 19-09-2024 | VALID |